ImmuCell Corporation (ICCC)

NASDAQ: ICCC · Real-Time Price · USD

8.38

+0.13 (1.58%)

At close: Apr 28, 2026, 4:00 PM EDT

8.35

-0.03 (-0.36%)

After-hours: Apr 28, 2026, 4:10 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Mastitis	196.39K	178.92K	177.74K	154.56K	143.28K
Mastitis Growth	9.76%	0.67%	15.00%	7.87%	-
Scours	27.45M	26.31M	17.29M	18.41M	18.93M
Scours Growth	4.31%	52.16%	-6.07%	-2.75%	-
Other	-	-	-	1.46K	166.60K
Other Growth	-	-	-	-99.13%	-
Total	27.64M	26.49M	17.47M	18.57M	19.24M
Total Growth	4.34%	51.64%	-5.90%	-3.51%	25.43%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	24.39M	22.89M	15.95M	17.02M	16.62M
United States Growth	6.54%	43.54%	-6.29%	2.41%	21.81%
Other	3.25M	3.60M	1.52M	1.55M	2.62M
Other Growth	-9.64%	136.45%	-1.61%	-41.01%	54.50%
Total	27.64M	26.49M	17.47M	18.57M	19.24M
Total Growth	4.34%	51.64%	-5.90%	-3.51%	25.43%

Source: S&P Global Market Intelligence.